chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Mar-2021: Significant Follow up Appended
Information regarding Flumist was received from a healthcare professional regarding a 20 year old female pt who experienced nausea, vomiting, and headache. At 20 years of age, the pt received a dose on 12/9/03. On 12/9/03, approximately one hour post vaccination, the pt experienced nausea, vomiting, and a headache. The pt still had a headache about four hours after vaccine administration. No additional info was available at the date of this report.
after she left to go home, cx said her throat was closing and could not swallow food and went to er.
Fever, aches, headache, Tylenol and rest. Recovered after 1 day
Nausea, weakness, dizzy, tired.  It progressed to throwing up and diarrhea.
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date the unspecified number of patients were vaccinated with improperly stored doses of GARDASIL (dose, dose number, route, anatomical location, lot number and expiration date were unspecified). Concomitant therapies were not reported. No adverse symptoms reported. This is one of several reports from the same reporter. Additional information has been requested.
pt recv vax MAY98 & JUN98 pt exp thrombocytopenia;the reporting MD noted that pt recently complete a course of immune globulin & is presently waiting for the results;
Typical soreness at the injection site, 3-4 hours after injection. Following morning, muscle stiffness in  lower back. 19 hours later, slight headache, lower back pain, across the back. 22 hrs later slight neck stiffness, no headache, muscle soreness in lower right side/back.
Mom reported event several weeks after the fact. Reports eruption of hives within hours of vaccine administration. Lasted several hours. Resolved before doctor appointment next day so she cancelled appointment. No treatment.
On 12/23/99, the pt received his first dose of Infanrix. Subsequently on 12/23/99 he screamed for two hours. Outcome: resolved. The most recent information received on 3/27/00 reports the condition of the pt as resolved.
16OCT93 1230PM-330PM unsettled behavior, very erratic would not go down for nap, creid for 2 hrs straight; 9PM screaming uncontrollable; 17OCT93 t102; 18OCT93 would not nap; 19OCT93 convuls, body stiffening, eyes rolled back, jerking body
red puffy warm oval shaped area; Warm oval shaped area near area of injection; puffy/oval shaped area near injection site; achy joints; fatigue; fever; This case was reported by a nurse via sales rep and described the occurrence of localized erythema in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (On 27th September 2019 received 1st dose refer case US2019AMR220055).   On 3rd December 2019, the patient received the 2nd dose of Shingrix. On 4th December 2019, 1 days after receiving Shingrix, the patient experienced localized erythema, localized feeling of warmth, tissue puffing, joint pain, fatigue and fever. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the localized erythema, localized feeling of warmth and tissue puffing were unknown and the outcome of the joint pain, fatigue and fever were recovered/resolved.   It was unknown if the reporter considered the localized erythema, localized feeling of warmth, tissue puffing, joint pain, fatigue and fever to be related to Shingrix.  Additional details were provided as follows: The patient experienced red,warm, puffy, oval shaped area near area of injection. In Addition to that, the patient aslo experienced joint pain, fatigue and fever. The patient felt better after out of bed.
I have sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (I have sore shoulder) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20N) for COVID-19 vaccination.     Concurrent medical conditions included Injury (The patient stated that he was taking hydrocortisone tablets and ibuprofen tablets anyways due to other injuries.). Concomitant products included HYDROCORTISONE and IBUPROFEN for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ARTHRALGIA (I have sore shoulder). At the time of the report, ARTHRALGIA (I have sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not provided.
Pain/heaviness in left arm; Sweats; Chills; Diahrea; Nausea; Weakness; Fatigue for 3 weeks; This is a spontaneous report received from a contactable health care professional (patient). This is the 1st of 2 reports, for the 1st dose. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK9231) via an unspecified route of administration on the left arm on 07Jan2021 at 17:00, as single dose for COVID-19 immunisation (age at vaccination 60-years-old). Medical history was reported as asthma, hypothyroidism, neuro damage in spine and wrists, vertigo, migraines (none in past 5-6 years), arthritis, and mood disorder. Concomitant medications included bromide, vilanterol trifenatate (ANORO); levothyroxine sodium (UNITHROID); paliperidone; valproate semisodium (DEPAKOTE). The patient previously took Darvon [dextropropoxyphene hydrochloride] and was allergic to it.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 08Jan2021 at 14:00, the patient experienced pain/heaviness in left arm, sweats, chills, diarrhea, nausea (nausea for 3 days), weakness, and fatigue (fatigue for 3 weeks). The patient received treatment for the reported events as an injection of a medication with high NSAID (non-steroidal anti-inflammatory drugs) levels. Patient visited the doctor or other healthcare professional office/clinic visit for adverse event. The events outcome were recovered with sequalae.   No follow-up attempts are needed. No further information is expected.
MY EYE BROWS SWELLED; DIZZINESS; CRAVED BLACK LICORICE LIKE MAD; MASSIVE EYE TEARING; HAD A RIGHT SIDED FRONTAL HEADACHE; POST NASAL DRIP; I FELT LIKE I WAS AT HIGH ALTITUDE WHICH LASTED FOR 36-48 HOURS.; This is a spontaneous report from a non-contactable non-health care professional. A 42-year-old female patient received BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine) (Lot/batch no: EN6199) dose number 1 via unspecified route of administration on left arm as a single dose for COVID-19 immunisation on 04Mar2021 at 06:30 PM (at the age of 42-year-old). Medical history included allergy to gold. Concomitant medication was not provided. Reported patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient experienced dizziness within the first 15 minutes. Within the first hour her eye brows swelled and she had a right sided frontal headache. 2 hours later she felt like she was at high altitude which lasted for 36-48 hours. The swelling broke during the night with massive eye tearing and post nasal drip. She craved for black licorice like mad on 04Mar2021. The action taken was not applicable. Therapeutic measures were taken as a result of events and included self-treatment with ice pack, tylenol, and clairitin from an unknown date. The patients recovered from the events dizziness, eye brows swelled, frontal headache, massive eye tearing and post nasal drip was recovered. No follow-up attempts are needed. No further information is expected.
should my chest be hurting; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (should my chest be hurting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (should my chest be hurting). At the time of the report, CHEST PAIN (should my chest be hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by the reporter. No treatment medications were reported by the reporter.
My mom suffered a stroke after the second Moderna COVID-19 vaccination. She can no longer walk and she is now wheelchair bound. She struggles to find words. Lost the use of her left side for three months. Has never recovered fully
continued combining Daptacel with ActHib with no reported adverse event; Initial information received on 23-Jan-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient where he/she continued combining daptacel with acthib with no reported adverse event while receiving vaccines HIB (prp/t) vaccine [act-HIB] and diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel].  The patient's past medical history, medical treatment(s), concomitant medication(s)(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect diphtheria-15/tetanus/5 ac pertussis vaccine Suspension for injection lot number not reported via unknown route in unknown administration site (dose, frequency, route, strength, lot/batch number and expiration date : not provided) as prophylactic vaccination and HIB (prp/t) vaccine Powder and solvent for solution for injection (dose, frequency, route, strength, lot/batch number and expiration date : not provided) as prophylactic vaccination.  On an unknown date the patient continued combining daptacel with acthib with no reported adverse event (vaccination error) (unknown latency) following the administration of diphtheria-15/tetanus/5 ac pertussis vaccine and HIB (prp/t) vaccine.  Action taken- Not applicable for both suspects.  At time of reporting, the outcome was Unknown for the event continued combining daptacel with acthib with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 20-MAY-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVIs 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -6.66 Celsius Degrees for 1176 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
TDAP given 5/11/15. Developed 2 lesions right upper arm-day later. Developed one lesion right wrist 5/13/15. Dx. erythema multiforme. No tx.
knee pain became very bad (joint and muscle); General body aches; Left arm (injection site) pain increased from elbow to shoulder; knee pain became very bad (joint and muscle); This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 17Mar2021 at 10:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included heart disease and arthritis in major joints and much of spine. The patient did not have allergies to medications, food, or other products. The patient received unspecified medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Mar2021 at 07:00, the patient experienced left arm pain at injection site which was increased from elbow to shoulder and knee pain became very bad (joint and muscle) and general body aches. The patient's both shoulder and knee already had bad arthritis. The patient reported that it took almost 72 hours to first develop joint and muscle aches and was especially bad in joints already with major arthritic related issues. All the events faded away after 02 days. The patient would get 2nd dose on 07Apr2021. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events left arm pain at injection site, knee pain became very bad (joint and muscle) and general body aches was resolved on an unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
At Hepatitis A Outreach, dose of pediatric vaccine taken out of cooler and given. Revaccinated on 11-2-2018 Hepatitis A R018775 Vaqta 2019Aug09.  Box of pediatric vaccine put in cooler instead of adult vaccine.
Immediate onset of L facial weakness/inability to fully close lips on L side (contract muscles) to seal lips when eating/drinking. Evaluated in ER and stroke ruled out by negative head CT and workup. Misdiagnosed as Bell's palsy, no treatment, told it could take several weeks or months to resolve and to wait it out. Upper lip tight and smile changed. Symptoms persisted and slowly worsened/progressed, overall muscle strength diminished, some bronchospasm issues with heavy exercise. Seen by PCP and allergy doctor and told likely has exercise-induced asthma and still resolving Bell's palsy. Facial symptoms continued to worsen and began involving his palate, unable to close off sinus passage way, slurred and nasal speech in the evenings, unable to chew and swallow well towards evening. Patient feared he had ALS after researching symptoms, I started to worry it was myasthenia gravis. Saw PCP again who refused to order confirmatory lab work for MG or ALS and referred to neurology. Referral turnaround was not emergent despite several calls and attempts to escalate this issue. Unable to verbally communicate in the evenings, resorted to texting to express needs. Had a scary episode of choking due to inability to swallow, 911 called to home. Sent to ER for workup and finally a neuromuscular disorder was on the differential. Transferred to a higher level of care for on-site neurology where he received IVIG x 5 days and started pyridostigmine for likely myasthenia gravis with rapid improvement in symtoms. Plan is for continued monthly IVIG and then adding an immunosuppressant long-term in addition to his pyridostigmine.
Neurological Symptoms -SEVERE and EXCRUCIATING muscle pain (myalgia) in legs and arms, worse in legs, numbness, burning, tingling, fatigue, severe cramping in feet and legs some weakness in legs.  Diagnosis Post Vaccination Syndrome, ADPN, neuropathy.  Subsequent nerve testing. Symptoms continue, treatment with medications continue.
?hair falling out diffuse;pt on med-well & has been;No skin/scalp problems;no psych or nutritional problem;
Pt. states that after receiving the 1st dose of J&J 08/20/2021, started experiencing symptoms immediately of shaking severe chest pains, loss of appetite, and chills. Still continuing, Primary recommendations "Wait it out".
breakthrough seizure and frequent seizures; This is a spontaneous report from a contactable consumer. A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in Arm Left on 16Apr2021 13:00 (1:00PM) (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient is not pregnant at the time of vaccination. Medical history included ongoing epilepsy and known allergies latex, bee stings from an unknown date and unknown if ongoing. No other vaccine in four weeks. The patient had no Covid prior vaccination and not Covid tested post vaccination. The patient was vaccinated at a facility. Concomitant medication included (reported as Other medications in two week): cenobamate (XCOPRI) and zonisamide (ZONISAMIDE); both taken for temporal lobe epilepsy, start and stop date were not reported. The patient previously took bnt162b2 for covid-19 immunisation first dose from 18Mar2021 at 01:00 PM in the left arm. The patient also previously took oxcarbazepine and experienced allergies (reported as Known allergies: Oxcarbazepine). It was reported that the patient has temporal lobe epilepsy well controlled on Xcopri(200mg) and zonisdamide(300mg) and experienced breakthrough seizure and frequent seizures during the last 14 hours (reported as 15Apr2021 at 08:00 PM [20:00]). Previously well controlled for the past 2-3 months, upon titration to current dose of zonisamide/xcopri. The outcome of the event was recovering. No treatment for the reported event.   Information on the lot/batch number has been requested.
1) fever - start 8/28/21 @ 9PM 2) cough - start 8/28/21 @ 9 PM, continuation 3) axillary jelly like mall, size of egg @ this time.
Per retrospective review... Pt. reported history of swollen arm and fever related to MMR vaccine in the past; no other significant medical history.     Pt. reported insertion site reaction after COVID vaccine dose #1.     After dose #2, patient reported fatigue on Day 1 following administration date.   Presented to Emergency Department on Day 2 following admin date with mildly itchy rash on anterior torso.  Also per note, injection site redness.  No pain.  Reported dry cough "every now and then."  Pt. showed nor signs of anaphylaxis or differentials.  Released with recommendation to treat mild delayed hypersensitivity reaction with OTC ceterizine or diphenhydramine and follow-up with primary care..
feeling sick; nausea; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced MALAISE (feeling sick), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 15-Apr-2021, MALAISE (feeling sick), NAUSEA (nausea), CHILLS (chills) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment also includes fluids like water and juice
Paralyzed from waist down. Couldn't walk or crawl. Screaming crying after vaccination for a few days. Sleeping in a backwards C position. Irritable. Upset. Lots of crying and spacing out.
Information has been received from a health professional concerning a 5 year old male who at about 12 months of age, in approximately December 2000, was vaccinated with a dose of varicella virus vaccine live.  The child was seen in the office on 02/07/2005 with about 200 to 250 varicella lesions all over his body including inside the mouth and ears.  He also had a low grade fever.  He was treated with acyclovir and diphenhydramine hcl, and will be observed with a follow up visit.  The patient is currently recovering.  No product quality complaint was involved.  Additional information has been requested.
Patient had swelling and pain in left shoulder. The patient went to the Emergency room the following morning (9/17) for the pain and swelling. The hospital administered a pain injection to help with the pain. The patient ad provider states they are doing okay and stable, although still some swelling and pain.
gland swelling under chin, upper neck; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received bnt162b2 (BNT162B2, Pfizer Covid-19 vaccine), dose 2 via an unspecified route of administration, administered in left arm on 30Jan2021 12:30 (Lot Number: EN5318) as single dose for covid-19 immunization. Medical history included ongoing diabetes type 2. There were no concomitant medications. The patient received dose 1 (lot: EL3246) on 09Jan2021 for Covid-19 immunisation. The patient experienced gland swelling under chin, upper neck in Apr2021.  The patient underwent lab tests and procedures which included ultrasound thyroid with unknown result on 08Apr2021. The outcome was recovering.  No follow-up attempts are needed. No further information is expected.
p/vax pt devel an infect around lt arm c/o fever, swelling;seen @ urgent care 9/26/99 & was put on ATB AM;
Pt presented to observation post 2nd Moderna vaccine- had been advised to remain in observation for 30 minutes. @6:00 PM pt walked up to observation RN to express "something is not right, I dont feel right and my teeth are chattering and my hands are tremoring" Pt was able to walk back to sit in a chair  Initial BP was 225/205 and pt began to c/o feeling "I feel faint, very tired all of a sudden"  RN advised CNA to alert staff for help  Pt then began to wheeze and cough.  Per adverse drug reaction kit IM Epinephrine 0.3 mg  administered @ 6:05 pm  911 called. Within 2 minutes pt expressed "I feel better now" teeth chattering, fatigue and cough resolved.  EMS arrived, son arrived  Pt w/s/s similar to arrival at time of transport but lessened, pt left via stretcher to Hospital@6 bp recheck at time of discharge 169/64 Staff RN